Literature DB >> 6411729

Arachidonic acid stimulates the formation of 1,2-diacylglycerol and phosphatidic acid in human platelets. Degree of phospholipase C activation correlates with protein phosphorylation, platelet shape change, serotonin release, and aggregation.

W Siess, F L Siegel, E G Lapetina.   

Abstract

Exogenous unlabeled arachidonic acid (AA) added to human platelets prelabeled with [3H]AA induces breakdown of [3H]phosphatidylinositol and the rapid and transient formation of [3H]1,2-diacylglycerol and [3H]phosphatidic acid (PA), indicating activation of phosphatidylinositol-specific phospholipase C. Formation of [3H]1,2-diacylglycerol and [3H]PA is inhibited by pretreatment of platelets with aspirin, which suggests that endoperoxides or thromboxane A2 are responsible for AA-induced stimulation of phospholipase C. Exogenous unlabeled AA also induces the formation of [32P]PA or [14C]PA in platelets that have been prelabeled with 32Pi or [14C]AA, respectively. Increased radioactivity in PA reflects increased content of PA as measured by the fatty acid composition of PA. The relation of PA production, which reflects stimulation of phospholipase C, to specific platelet responses was further investigated. Low concentrations of AA (0.05-0.2 microM) induces platelet shape change in parallel to formation of 50-100% PA and phosphorylation of a 40,000 molecular weight protein. Higher concentrations of AA (0.5-50 microM) stimulate the formation of a further amount of PA (200-250%), and phosphorylation of 40,000 molecular weight protein, platelet aggregation, and serotonin release. Indomethacin inhibits all these observed changes by inhibiting the conversion of AA by platelet cyclooxygenase. In contrast, prostacyclin blocks these responses without affecting conversion of AA by platelet cyclooxygenase and thromboxane synthetase. We conclude that formation of endoperoxides and thromboxane A2 is necessary but not sufficient for platelet activation by AA. Only if PA is formed are platelets activated. The results indicate a central role for the phospholipase C pathway in the process of platelet activation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411729

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Phospholipase A2 and its potential regulation of islet function.

Authors:  E Simonsson; B Ahrén
Journal:  Int J Pancreatol       Date:  2000-02

2.  A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets.

Authors:  D L Nunn; S P Watson
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

3.  Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet.

Authors:  D de Chaffoy de Courcelles; P Roevens; H Van Belle
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

4.  Agonist-evoked changes in cytosolic pH and calcium concentration in human platelets: studies in physiological bicarbonate.

Authors:  S O Sage; T M Jobson; T J Rink
Journal:  J Physiol       Date:  1990-01       Impact factor: 5.182

5.  Aggregation and/or oxygenated products of arachidonic acid are not required for collagen-induced deacylation of phosphatidylcholine in human platelets.

Authors:  L A Piché; V G Mahadevappa
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

6.  Potentiation of specific association of insulin with HepG2 cells by phorbol esters.

Authors:  A D Blake; C D Strader
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

7.  myo-Inositol 1,4,5-trisphosphate stimulates protein phosphorylation in saponin-permeabilized human platelets.

Authors:  E G Lapetina; S P Watson; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Activation of human platelet phospholipase C by ionophore A23187 is totally dependent upon cyclo-oxygenase products and ADP.

Authors:  S E Rittenhouse
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

9.  Activation of phospholipase C and prostaglandin synthesis by [arginine]vasopressin in cultures.

Authors:  J Pfeilschifter; A Kurtz; C Bauer
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

10.  Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry.

Authors:  Sandra M Penz; Isabell Bernlochner; Orsolya Tóth; Reinhard Lorenz; Andreas Calatzis; Wolfgang Siess
Journal:  Thromb J       Date:  2010-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.